Cell Line Development: A Gold Mine for Service Providers
Owing to their use in the manufacturing of biologics and biosimilars, and various application areas, such as drug screening, gene functional studies, cell-based assay development, diagnostics and tissue engineering, there is growing demand for different types of cell lines. The ‘Cell Line Development Services Market, 2017 – 2027’ report provides an extensive study of the rapidly growing market of cell lines. Mentioned below are a few key takeaways from the report.
US and EU: The Key Service Hubs
Approximately 80% of the players are located in North America and the EU; within Asia Pacific, China and India have emerged as popular hubs
Fragmented, But Well-Distributed, Market Landscape
Both well-established and mid-sized players, and start-ups, are actively involved in the development and production of cell lines
Multiple Cell Line Procurement Sources for a Range of Applications
High-yielding cell lines can be derived from multiple sources and, given the evolution of the biopharmaceutical market, are being used for several purposes
Service Providers Aiming for Expansion …
Companies are rapidly expanding their service offerings and technology platforms in order to maintain a competitive edge in the market
… Are Gradually Widening Services Portfolio
In fact, several players already provide affiliated services, such as cell line characterization and cell banking, as integral parts of their respective services portfolios
A Steadily Growing Billion Dollar Market
Driven by the robust and promising pipeline of biotherapeutics, the cell line development services market is anticipated to witness steady growth in the coming decade
Emerging Novel and Innovative Technologies
The heightened competition and growing demand for cell lines has resulted in the emergence of several novel and innovative technologies, lowering of manufacturing costs and production timelines. Examples of some companies that have developed proprietary technologies for production of cell lines include (in alphabetical order) Abzena (Composite CHO™ technology), ACROBiosystems (HEKMax® Stable Cell Line Technology), BioFactura (StableFast™ Biomanufacturing Platform), Batavia Biosciences (STEP® technology), Celltheon (SMART™ expression platform), Celonic (CHOvolution™ / SEFEX platform), Cevec Pharmaceuticals (CAP®GO platform) and Selexis (SUREtechnology Platform™)
To learn more, please click here. For any queries / suggestions or if you’d like to get access to the full research results, please do not hesitate to contact us at sales@rootsanalysis.com
For further information on this domain, check our report here.
Roots Analysis – Leaders in Pharmaceutical & Biotechnology Market Research
You may also be interested in the following titles:
Inhaled and Intranasal Drug Delivery: A Deeper Look into Service Providers Landscape
Gene Therapies: Mapping the Future Growth Potential
Back of the Eye Disorders: The Emergence of Novel Drugs and Delivery Technologies
About Author
